Cargando…
Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis
BACKGROUND: Emerging experimental and epidemiological evidence highlights a crucial cross-talk between the intestinal flora and the lungs, termed the “gut-lung axis”. However, the function of the gut microbiota in bronchiectasis remains undefined. In this study, we aimed to perform a multi-omics-bas...
Autores principales: | Wang, Wen-Wen, Mao, Bei, Liu, Yang, Gu, Shu-Yi, Lu, Hai-Wen, Bai, Jiu-Wu, Liang, Shuo, Yang, Jia-Wei, Li, Jian-Xiong, Su, Xiao, Hu, Hai-Yang, Wang, Chen, Xu, Jin-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675243/ https://www.ncbi.nlm.nih.gov/pubmed/36403022 http://dx.doi.org/10.1186/s12931-022-02229-w |
Ejemplares similares
-
Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study
por: Wang, Hong, et al.
Publicado: (2018) -
The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021) -
Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis
por: Fan, Li-Chao, et al.
Publicado: (2015) -
Down‐expression of Foxj1 on airway epithelium with impaired cilia architecture in non‐cystic fibrosis bronchiectasis implies disease severity
por: Zou, Xiao‐Ling, et al.
Publicado: (2023) -
Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study
por: Wei, Ping, et al.
Publicado: (2016)